Literature DB >> 22072576

Two promoters with distinct activities in different tissues drive the expression of heparanase in Xenopus.

Gabriel E Bertolesi1, Hsiao Yuan Su, George Michaiel, Stephanie M Dueck, Carrie L Hehr, Sarah McFarlane.   

Abstract

In Xenopus laevis embryos, heparanase, the enzyme that degrades heparan sulfate, is synthesized as a preproheparanase (XHpaL) and processed to become enzymatically active (XHpa active). A short nonenzymatic heparanase splice variant (XHpaS) is also expressed. Using immunohistochemistry, Western blot, and heparanase promoter analysis, we studied the dynamic developmental expression of the three heparanases. Our results indicate that (1) all three isoforms are maternally expressed; (2) XHpaS is a developmental variant; (3) in the early embryo, heparanase is localized to both the plasma membrane and the nucleus; (4) several tissues express heparanase, but expression in the developing nervous system is most evident; (5) two promoters with distinct activities in different tissues drive heparanase expression; (6) Oct binding transcription factors may modulate heparanase promoter activity in the early embryo. These data argue that heparanase is expressed widely during development, but localization and levels are finely regulated.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22072576     DOI: 10.1002/dvdy.22770

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  7 in total

1.  Fibroblast growth factor receptor 1 signaling transcriptionally regulates the axon guidance cue slit1.

Authors:  Jung-Lynn Jonathan Yang; Gabriel E Bertolesi; Carrie L Hehr; Jillian Johnston; Sarah McFarlane
Journal:  Cell Mol Life Sci       Date:  2018-04-28       Impact factor: 9.261

2.  DNA methylation of heparanase promoter influences its expression and associated with the progression of human breast cancer.

Authors:  Fei Jiao; Shi-Yu Bai; Ying Ma; Zhong-Hai Yan; Zhen Yue; Yuan Yu; Xin Wang; Juan Wang
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

3.  The Expression of Key Guidance Genes at a Forebrain Axon Turning Point Is Maintained by Distinct Fgfr Isoforms but a Common Downstream Signal Transduction Mechanism.

Authors:  Jung-Lynn Jonathan Yang; Gabriel E Bertolesi; Stephanie Dueck; Carrie L Hehr; Sarah McFarlane
Journal:  eNeuro       Date:  2019-04-09

Review 4.  Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies.

Authors:  Hailong Tian; Tingting Zhang; Siyuan Qin; Zhao Huang; Li Zhou; Jiayan Shi; Edouard C Nice; Na Xie; Canhua Huang; Zhisen Shen
Journal:  J Hematol Oncol       Date:  2022-09-12       Impact factor: 23.168

5.  Clinical significance of heparanase splice variant (t5) in renal cell carcinoma: evaluation by a novel t5-specific monoclonal antibody.

Authors:  Uri Barash; Gil Arvatz; Roy Farfara; Inna Naroditsky; Ilana Doweck; Sari Feld; Ofer Ben-Izhak; Neta Ilan; Ofer Nativ; Israel Vlodavsky
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

6.  Heparin and liver heparan sulfate can rescue hepatoma cells from topotecan action.

Authors:  József Dudás; József Bocsi; Alexandra Fullár; Kornélia Baghy; Tibor Füle; Saule Kudaibergenova; Ilona Kovalszky
Journal:  Biomed Res Int       Date:  2014-09-07       Impact factor: 3.411

7.  Heparanase 2, mutated in urofacial syndrome, mediates peripheral neural development in Xenopus.

Authors:  Neil A Roberts; Adrian S Woolf; Helen M Stuart; Raphaël Thuret; Edward A McKenzie; William G Newman; Emma N Hilton
Journal:  Hum Mol Genet       Date:  2014-04-01       Impact factor: 6.150

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.